©The Author(s) 2025.
World J Cardiol. Oct 26, 2025; 17(10): 111462
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.111462
Published online Oct 26, 2025. doi: 10.4330/wjc.v17.i10.111462
Figure 8 Endocrinopathies and genes involved in cardiomyopathies.
MEN1: Multiple endocrine neoplasia type 1; MEN2: Multiple endocrine neoplasia type 2; SDHB: Succinate dehydrogenase complex subunit B; SDHD: Succinate dehydrogenase complex subunit D; PRKAR1A: Protein kinase cAMP-dependent type I regulatory subunit alpha; GNAS: GNAS complex locus; THSR: Thyroid hormone receptor; HNF1A: Hepatocyte nuclear factor 1 alpha; HNF4A: Hepatocyte nuclear factor 4 alpha; MODY: Maturity-onset diabetes of the young; GH: Growth hormone; IGF-1: Insulin-like growth factor 1; TGF-β1: Transforming growth factor beta 1; sST2: Soluble suppression of tumorigenicity 2; microRNAs: Micro ribonucleic acids; PET: Positron emission tomography; CM: Cardiomyopathy.
- Citation: Fuentes-Mendoza JM, Concepción-Zavaleta MJ, Morón-Siguas JC, Muñoz-Moreno JM, Pérez-Reyes AI, Martinez-Galaviz R, Aguilar-Castañeda RD, González-Godoy O, Concepción-Urteaga LA, Paz-Ibarra J. Cardiomyopathies of endocrine origin: A state-of-the-art review. World J Cardiol 2025; 17(10): 111462
- URL: https://www.wjgnet.com/1949-8462/full/v17/i10/111462.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i10.111462